Harbour Asset Management Boosts Ryman Healthcare Stake to 6.66% After $91.7 Million in Market Purchases

Harbour Asset Management's Ryman Healthcare Holdings Surpass 67.6 Million Shares

As of 30 June 2026, Harbour Asset Management Limited holds 67,653,109 ordinary shares in Ryman Healthcare, equating to 6.661% of the total ordinary share class comprising 1,015,729,081 shares. This contrasts with its prior holding of 51,514,714 shares (5.575%) disclosed on 4 March 2025. The increase of more than 1% in ownership triggers mandatory disclosure obligations under the Financial Markets Conduct Act 2013, requiring substantial product holders to notify both NZX Limited and the listed company when their stake changes by 1% or more.

The net addition of roughly 16.1 million shares over the approximately 16-month period highlights a purposeful and sustained accumulation strategy by Harbour. Additionally, the total shares on issue increased from 924,051,375 at the last disclosure to 1,015,729,081 at present, indicating Ryman Healthcare issued additional shares during this time. Harbour’s purchasing activity was sufficient to increase its proportional ownership despite this expanded share base.

$91.7 Million in Purchases Offset by $49.3 Million in Sales Since March 2025

The disclosure details Harbour Asset Management’s on-market purchases of 35,577,034 Ryman Healthcare shares for a gross consideration of $91,671,745.55 between 4 March 2025 and 30 June 2026. Concurrently, Harbour sold 19,438,639 shares for $49,312,079.26 gross. The net effect of these transactions—a combination of buying and selling as part of managing client funds—is a net increase of approximately 16,138,395 shares, driving the ownership percentage from 5.575% to 6.661%.

These figures reflect Harbour’s active trading approach rather than a simple buy-and-hold strategy. Fund managers typically trade continuously across multiple client accounts, and the gross figures represent aggregate activity across Harbour’s client base. Overall, Harbour’s portfolio positioning shifted meaningfully toward increased exposure to Ryman Healthcare during this period.

BNZ Investment Services Limited’s Separate 1.620% Stake Managed by Harbour

The disclosure also reveals BNZ Investment Services Limited (BNZIL), a wholly-owned subsidiary of BNZ Investments Limited, holds 16,451,433 Ryman Healthcare shares, representing 1.620% of the total share class. These shares are managed by Harbour Asset Management under an investment management agreement, forming part of Harbour’s broader relevant interest but representing a distinct beneficial ownership.

BNZIL’s activity includes on-market purchases of 8,221,252 shares for $21,971,060.27 gross and sales of 4,497,202 shares for $11,057,573.27 gross since the previous disclosure. Combined, Harbour’s direct holdings and BNZIL-managed assets represent over 8% of Ryman Healthcare’s total ordinary shares, although Harbour’s formal disclosed substantial holding remains at 6.661%.

FirstCape’s Indirect Control Over Harbour’s Voting and Disposal Rights in Ryman

The corporate structure disclosed shows Harbour Asset Management Limited as a wholly-owned subsidiary of FirstCape, which thus holds voting and disposal powers over Ryman Healthcare shares indirectly through Harbour. This is a standard institutional arrangement where the parent entity is deemed to have relevant interest in shares managed by subsidiaries, despite day-to-day investment decisions being made by the fund manager.

Harbour holds the power to exercise or control voting rights and to acquire or dispose of shares under investment powers granted by trust deeds or management agreements with clients. This structure is typical among New Zealand and Australian fund managers and does not indicate unusual governance. The disclosure was certified by Madeleine Pumphrey of JBWere on Harbour’s behalf.

On-Market Transaction Procedures and Custodian Arrangements for Ryman Shares

The disclosure notes that on-market purchases were registered under "Unknown" at announcement time, a common occurrence between trade execution and settlement. Once transfers are registered, shares are held by various nominees or custodians on Harbour’s behalf, standard for institutional investors using omnibus or nominee accounts.

For on-market sales, registered holders at disclosure were various nominees or custodians for Harbour, with post-transfer holders listed as "Unknown." These procedural details reflect institutional settlement mechanics rather than substantive changes in ownership. Investors should focus on net changes in holdings rather than custodial technicalities.

Ryman Healthcare’s Growing Share Base Contextualizes Harbour’s Accumulation

The total Ryman Healthcare ordinary shares increased from 924,051,375 on 4 March 2025 to 1,015,729,081 on 30 June 2026—an approximate 9.9% rise, or 91.7 million shares. This suggests Ryman undertook capital raising or issued shares by other means during this period, which typically dilutes existing shareholders who do not participate.

Despite this dilution, Harbour’s ownership rose from 5.575% to 6.661%, indicating its net purchases more than offset dilution. This accumulation amid an expanding share register may be viewed as a strong endorsement from a major New Zealand institutional asset manager, though fund manager activity can reflect diverse client mandates and portfolio rebalancing rather than a single investment thesis.

Implications of Disclosure Timing for Ryman’s Institutional Shareholder Base

The relevant event date of 30 June 2026 aligns with the financial half-year end for many New Zealand and Australian institutional investors, a period often associated with portfolio rebalancing and mandate reviews. The disclosure filed on 1 July 2026 indicates the 1% ownership threshold was crossed during the final trading session of the half-year or cumulatively in June.

Harbour’s previous disclosure was on 4 March 2025, meaning over 15 months elapsed between substantial holder notices. During this time, Harbour actively traded Ryman shares on both sides of the market, as shown by significant gross purchase and sale volumes. The absence of earlier disclosures suggests the net position change remained below 1% until recently.

Ryman Healthcare’s Role in the Retirement Village Sector and Investor Attention

Ryman Healthcare is a leading retirement village and aged care operator in New Zealand and Australia, managing integrated villages with independent living, serviced apartments, and aged care facilities. It is a longstanding NZX 50 constituent and dual-listed on the ASX, attracting institutional interest from both New Zealand and Australian fund managers.

Harbour Asset Management’s increased accumulation may attract attention from market participants tracking substantial shareholder register changes as indicators of institutional sentiment. This announcement suggests Harbour has been a consistent net buyer over the past 15 months. However, investors should perform their own due diligence and consider all factors affecting Ryman’s outlook before inferring implications for share price. No immediate share price impact was evident from public information.

Future Disclosure Requirements and Monitoring of Ryman’s Shareholder Register

Under the Financial Markets Conduct Act 2013, Harbour must disclose any further changes of 1% or more from the current 6.661% stake, whether through accumulation or selling. Market observers should watch for future filings indicating whether Harbour’s accumulation continues or reverses.

The disclosure states no other parties are known to have given or be required to give disclosures under the Act related to these financial products. Thus, this filing pertains solely to Harbour and its associated entities. As Ryman executes its business strategy across New Zealand and Australia, shifts in its institutional shareholder base, including movements by other substantial holders, will be important for investors monitoring the register.